Figure 2.

The follow-up of glucose control and renal lesions in patients with DN (n = 264): A, mean change in Scr (%); B, mean change in fasting glucose; C, cumulative incidence (%) of end-stage renal disease: patients with obesity have improved renal survival compared those with lean BMI (Kaplan–Meier analysis, log-rank, P= 0.0231); D, mean change in BMI (%).

Chen et al. BMC Nephrology 2013 14:69   doi:10.1186/1471-2369-14-69
Download authors' original image